Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Heeney

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Haematologica|February 17, 2005
Risk of cholelithiasis in sickle cell anemiaMatthew M Heeney
Hematology. American Society of Hematology. Education Program|February 20, 2015
Iron clad: iron homeostasis and the diagnosis of hereditary iron overloadMatthew M Heeney
Pediatric Blood & Cancer|July 16, 2008
Cefepime-induced neutropenia in a teenagerSimone Hettmer, Matthew M Heeney
Hematology/Oncology Clinics of North America|October 30, 2004
Iron homeostasis and inherited iron overload disorders: an overviewMatthew M Heeney, Nancy C Andrews
Pediatric Clinics of North America|April 3, 2008
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pediatric Blood & Cancer|April 21, 2012
Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in childrenJohn J Strouse, Matthew M Heeney
Pediatric Clinics of North America|May 28, 2018
A Scientific Renaissance: Novel Drugs in Sickle Cell DiseaseAhmar U Zaidi, Matthew M Heeney
Hematology/Oncology Clinics of North America|July 28, 2014
Iron-refractory iron deficiency anemia (IRIDA)Matthew M Heeney, Karin E Finberg
Hematology/Oncology Clinics of North America|July 28, 2014
Iron disordersMatthew M Heeney, Alan R Cohen
Hematology/Oncology Clinics of North America|February 2, 2010
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Haematologica|February 17, 2005
Risk of cholelithiasis in sickle cell anemiaMatthew M Heeney
Hematology. American Society of Hematology. Education Program|February 20, 2015
Iron clad: iron homeostasis and the diagnosis of hereditary iron overloadMatthew M Heeney
Pediatric Blood & Cancer|July 16, 2008
Cefepime-induced neutropenia in a teenagerSimone Hettmer, Matthew M Heeney
Hematology/Oncology Clinics of North America|October 30, 2004
Iron homeostasis and inherited iron overload disorders: an overviewMatthew M Heeney, Nancy C Andrews
Pediatric Clinics of North America|April 3, 2008
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pediatric Blood & Cancer|April 21, 2012
Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in childrenJohn J Strouse, Matthew M Heeney
Pediatric Clinics of North America|May 28, 2018
A Scientific Renaissance: Novel Drugs in Sickle Cell DiseaseAhmar U Zaidi, Matthew M Heeney
Hematology/Oncology Clinics of North America|July 28, 2014
Iron-refractory iron deficiency anemia (IRIDA)Matthew M Heeney, Karin E Finberg
Hematology/Oncology Clinics of North America|July 28, 2014
Iron disordersMatthew M Heeney, Alan R Cohen
Hematology/Oncology Clinics of North America|February 2, 2010
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pageof 10